Prominent efficacy from capecitabine mono-therapy for a case with lymphangiosis carcinomatosa derived from recurrent breast cancer

Tadahiro Nozoe, Emiko Mori, Mayuko Kono, Tomohiro Iguchi, Takashi Maeda, Akito Matsukuma, Takahiro Ezaki

Research output: Contribution to journalArticle

Abstract

We met a 61-year-old woman who had been suffering from dyspnea due to pleuritis carcinomatosa derived from recurrent breast cancer for which no former chemotherapy had been effective. Capecitabine mono-therapy could exert a drastic anticancer effect for lymphangiosis carcinomatosa causing more severe symptoms of dyspnea. This therapeutic option could be selected for patients with recurrent breast cancer for which the first- or second-line chemotherapy could not provide a sufficient anti-cancer efficacy and possibly serve to sustain the life quality of the patients.

Original languageEnglish
Pages (from-to)427-429
Number of pages3
JournalJapanese Journal of Cancer and Chemotherapy
Volume38
Issue number3
Publication statusPublished - Mar 15 2011

Fingerprint

Dyspnea
Breast Neoplasms
Drug Therapy
Pleurisy
Quality of Life
Therapeutics
Neoplasms
Capecitabine

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Prominent efficacy from capecitabine mono-therapy for a case with lymphangiosis carcinomatosa derived from recurrent breast cancer. / Nozoe, Tadahiro; Mori, Emiko; Kono, Mayuko; Iguchi, Tomohiro; Maeda, Takashi; Matsukuma, Akito; Ezaki, Takahiro.

In: Japanese Journal of Cancer and Chemotherapy, Vol. 38, No. 3, 15.03.2011, p. 427-429.

Research output: Contribution to journalArticle

Nozoe, Tadahiro ; Mori, Emiko ; Kono, Mayuko ; Iguchi, Tomohiro ; Maeda, Takashi ; Matsukuma, Akito ; Ezaki, Takahiro. / Prominent efficacy from capecitabine mono-therapy for a case with lymphangiosis carcinomatosa derived from recurrent breast cancer. In: Japanese Journal of Cancer and Chemotherapy. 2011 ; Vol. 38, No. 3. pp. 427-429.
@article{0cc428abdc3f4c41a4189892e4a8a5dd,
title = "Prominent efficacy from capecitabine mono-therapy for a case with lymphangiosis carcinomatosa derived from recurrent breast cancer",
abstract = "We met a 61-year-old woman who had been suffering from dyspnea due to pleuritis carcinomatosa derived from recurrent breast cancer for which no former chemotherapy had been effective. Capecitabine mono-therapy could exert a drastic anticancer effect for lymphangiosis carcinomatosa causing more severe symptoms of dyspnea. This therapeutic option could be selected for patients with recurrent breast cancer for which the first- or second-line chemotherapy could not provide a sufficient anti-cancer efficacy and possibly serve to sustain the life quality of the patients.",
author = "Tadahiro Nozoe and Emiko Mori and Mayuko Kono and Tomohiro Iguchi and Takashi Maeda and Akito Matsukuma and Takahiro Ezaki",
year = "2011",
month = "3",
day = "15",
language = "English",
volume = "38",
pages = "427--429",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "3",

}

TY - JOUR

T1 - Prominent efficacy from capecitabine mono-therapy for a case with lymphangiosis carcinomatosa derived from recurrent breast cancer

AU - Nozoe, Tadahiro

AU - Mori, Emiko

AU - Kono, Mayuko

AU - Iguchi, Tomohiro

AU - Maeda, Takashi

AU - Matsukuma, Akito

AU - Ezaki, Takahiro

PY - 2011/3/15

Y1 - 2011/3/15

N2 - We met a 61-year-old woman who had been suffering from dyspnea due to pleuritis carcinomatosa derived from recurrent breast cancer for which no former chemotherapy had been effective. Capecitabine mono-therapy could exert a drastic anticancer effect for lymphangiosis carcinomatosa causing more severe symptoms of dyspnea. This therapeutic option could be selected for patients with recurrent breast cancer for which the first- or second-line chemotherapy could not provide a sufficient anti-cancer efficacy and possibly serve to sustain the life quality of the patients.

AB - We met a 61-year-old woman who had been suffering from dyspnea due to pleuritis carcinomatosa derived from recurrent breast cancer for which no former chemotherapy had been effective. Capecitabine mono-therapy could exert a drastic anticancer effect for lymphangiosis carcinomatosa causing more severe symptoms of dyspnea. This therapeutic option could be selected for patients with recurrent breast cancer for which the first- or second-line chemotherapy could not provide a sufficient anti-cancer efficacy and possibly serve to sustain the life quality of the patients.

UR - http://www.scopus.com/inward/record.url?scp=79957957455&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79957957455&partnerID=8YFLogxK

M3 - Article

C2 - 21403447

AN - SCOPUS:79957957455

VL - 38

SP - 427

EP - 429

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 3

ER -